Entera Bio Ltd. (ENTX) income statement
ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.31+0.03 (+0.76%)
Close on Nov 20, 2026Market cap $572.23MP/E –Yield –
Entera Bio Ltd. financial ratios
See a number that looks wrong?